Skip to main content
. 2017 Aug 4;135(2):85–96. doi: 10.1007/s10633-017-9601-2

Fig. 6.

Fig. 6

a Mean best-corrected visual acuity changes during the study measured in ETDRS letters. Eyes improved significantly the visual acuity at 6 months and then, remained stable. b Mean, central retinal thickness changes during the study. Eyes reduced significantly the CRT after being treated with ranibizumab. c Total macular volume changes during the study. Eyes reduced significantly the TMV at the end of the study